Hikal Limited (HIKAL.BO)
- Previous Close
308.70 - Open
309.55 - Bid 312.55 x --
- Ask 312.90 x --
- Day's Range
308.40 - 316.00 - 52 Week Range
258.60 - 331.05 - Volume
35,581 - Avg. Volume
24,445 - Market Cap (intraday)
38.507B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
53.75 - EPS (TTM)
5.81 - Earnings Date May 27, 2024 - May 31, 2024
- Forward Dividend & Yield 1.20 (0.38%)
- Ex-Dividend Date Feb 20, 2024
- 1y Target Est
224.00
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India. The company operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. It also collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, the company offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. It also exports its products. The company operates in the United States, Canada, Europe Union, Japan, Latin America, and internationally. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
www.hikal.com2,142
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: HIKAL.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HIKAL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HIKAL.BO
Valuation Measures
Market Cap
38.51B
Enterprise Value
45.76B
Trailing P/E
53.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.15
Price/Book (mrq)
3.36
Enterprise Value/Revenue
2.55
Enterprise Value/EBITDA
17.89
Financial Highlights
Profitability and Income Statement
Profit Margin
3.94%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
18.16B
Net Income Avi to Common (ttm)
716.22M
Diluted EPS (ttm)
5.81
Balance Sheet and Cash Flow
Total Cash (mrq)
361M
Total Debt/Equity (mrq)
67.54%
Levered Free Cash Flow (ttm)
--
Research Analysis: HIKAL.BO
Company Insights: HIKAL.BO
HIKAL.BO does not have Company Insights